Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Regimens containing clindamycin plus aminoglycoside showed no clear difference in clinical cure according to criteria established by authors Severe PID compared with regimens containing quinolone (low certainty).
It is very uncertain whether regimens containing clindamycin plus aminoglycoside changes microbiological clearance compared with regimens containing quinolone (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Regimens containing macrolides (azithromycin) showed no clear difference in clinical cure according to criteria established by study authors… compared with regimens containing tetracycline (doxycycline) (low certainty).
The review found no eligible studies for this question.
Regimens containing clindamycin plus aminoglycoside showed no clear difference in clinical cure according to criteria established by authors… compared with regimens containing cephalosporin (low certainty).
Regimens containing clindamycin plus aminoglycoside showed no clear difference in clinical cure according to criteria established by authors Severe PID compared with regimens containing cephalosporin (moderate certainty).
It is very uncertain whether regimens containing clindamycin plus aminoglycoside changes microbiological clearance compared with regimens containing cephalosporin (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Regimens containing macrolides (azithromycin) showed no clear difference in microbiological clearance compared with regimens containing tetracycline (doxycycline); GRADE not reported.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Regimens containing quinolone showed no clear difference in clinical cure according to criteria established by study authors… compared with regimens containing cephalosporins (low certainty).
Rufinamide probably leads to higher 50% or greater reduction in seizure frequency ‐ ITT analysis compared with placebo (moderate certainty).
Rufinamide may leads to higher adverse effects: diplopia compared with placebo (low certainty).
Rufinamide showed no clear difference in seizure freedom compared with placebo (moderate certainty).